Clinical trial
Resynchronization/Defibrillation for Ambulatory Heart Failure Trial
NCT00251251 · Ottawa Heart Institute Research Corporation, Other · Completed
Key facts
| NCT number | NCT00251251 |
|---|---|
| Title | Resynchronization/Defibrillation for Ambulatory Heart Failure Trial |
| Official title | Resynchronization/Defibrillation for Ambulatory Heart Failure Trial |
| Acronym | RAFT |
| Lead sponsor | Ottawa Heart Institute Research Corporation, Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) Medtronic Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Heart Failure, Congestive |
| Intervention type | Device |
| Interventions | Optimal Medical Therapy plus ICD, Optimal Medical Therapy plus CRT/ICD |
| Enrollment | 1,798 |
| Start date | Apr 1, 2003 |
| Primary completion | Sep 1, 2010 |
| Completion | May 1, 2011 |
| First posted | Nov 9, 2005 |
| Last update posted | Aug 28, 2023 |
| Countries | Australia, Belgium, Canada, Denmark, Germany, Netherlands, Turkey (Türkiye) |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: